Detalhe da pesquisa
1.
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries.
Am Heart J
; 220: 108-115, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809991
2.
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.
Eur Heart J Cardiovasc Pharmacother
; 6(1): 31-42, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511896
3.
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries.
Am J Cardiovasc Drugs
; 20(3): 259-269, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31586336
4.
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
Cardiol J
; 23(4): 374-83, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515481